CAMLINFINE CAMLINFINE NSE
Company Profile ↓Company Overview
CAMLINFINE (CAMLINFINE) is a publicly traded company listed on NSE with a market capitalization of ₹2,447.44 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 11.9% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹1,723.31 Cr (+5.8% YoY); net profit ₹27.63 Cr.
- Trailing 12 Months Year-on-year growth — revenue +5.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 11.9%, profit CAGR -6.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 11.94% |
| 1 Year: | 5.81% |
Compounded Profit Growth
| 5 Years: | -6.65% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -56.63% |
| 6 Months: | -17.63% |
| 3 Months: | +19.67% |
| 1 Month: | -8.10% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.65 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 11.9% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 88.5.
- Earnings shrank at -6.7% CAGR over 5 years.
- Trading 56.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 427.00 Cr | 420.00 Cr | 406.00 Cr | 386.00 Cr | 377.00 Cr | 381.00 Cr | 417.00 Cr | - | 431.58 Cr | 423.55 Cr | 459.82 Cr | 457.20 Cr | 424.81 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 210.80 Cr | 236.88 Cr | 246.72 Cr | 248.02 Cr | 218.79 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 220.79 Cr | 186.67 Cr | 213.10 Cr | 209.18 Cr | 206.02 Cr |
| Operating Expenses | 383.00 Cr | 381.00 Cr | 381.00 Cr | 363.00 Cr | 345.00 Cr | 352.00 Cr | 366.00 Cr | - | 175.88 Cr | 184.56 Cr | 195.66 Cr | 80.49 Cr | 205.65 Cr |
| Operating Income | 26.00 Cr | 20.00 Cr | 6.00 Cr | 2.00 Cr | 18.00 Cr | 14.00 Cr | 35.00 Cr | - | 44.91 Cr | 2.11 Cr | 17.44 Cr | 128.69 Cr | 37.12 L |
| EBITDA | 44.00 Cr | 39.00 Cr | 25.00 Cr | 23.00 Cr | 31.00 Cr | 29.00 Cr | 52.00 Cr | - | 63.70 Cr | 27.56 Cr | 33.94 Cr | 7.77 Cr | 42.71 Cr |
| Interest Expense | 10.00 Cr | 10.00 Cr | 20.00 Cr | 14.00 Cr | 16.00 Cr | 23.00 Cr | 26.00 Cr | - | 9.20 Cr | 14.90 Cr | 15.21 Cr | 18.90 Cr | 27.16 Cr |
| Pretax Income | 8.00 Cr | 16.00 Cr | -12.00 Cr | -10.00 Cr | -94.00 Cr | -23.00 Cr | -142.00 Cr | - | 37.36 Cr | -4.26 Cr | -9.23 L | -27.85 Cr | -5.26 Cr |
| Tax Provision | 4.72 Cr | 4.00 Cr | -8.64 Cr | -4.70 Cr | 12.22 Cr | -11.04 Cr | 25.56 Cr | - | 7.69 Cr | -1.00 L | 5.91 Cr | 4.52 L | -6.24 Cr |
| Net Income | 3.00 Cr | 12.00 Cr | -21.00 Cr | -14.00 Cr | -82.00 Cr | -35.00 Cr | -116.00 Cr | -4.14 Cr | -72.40 L | -9.96 Cr | -14.38 Cr | - | 88.20 Cr |
| Diluted EPS | 0.52 | 0.83 | -1.03 | -0.63 | -4.11 | -1.81 | -5.33 | - | -0.04 | -0.53 | -0.77 | -1.91 | 4.54 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 558.00 Cr | 489.00 Cr | 534.00 Cr | 721.00 Cr | 892.00 Cr | 1,049.00 Cr | 1,187.00 Cr | - | 1,671.30 Cr | 1,436.23 Cr | 1,628.69 Cr | 1,723.31 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 830.37 Cr | 792.81 Cr | 823.52 Cr | 922.45 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 840.93 Cr | 643.42 Cr | 805.17 Cr | 800.86 Cr |
| Operating Expenses | 474.00 Cr | 397.00 Cr | 502.00 Cr | 705.00 Cr | 819.00 Cr | 914.00 Cr | 1,000.00 Cr | - | 678.94 Cr | 479.68 Cr | 650.08 Cr | 764.90 Cr |
| Operating Income | 68.00 Cr | 75.00 Cr | 10.00 Cr | -11.00 Cr | 44.00 Cr | 102.00 Cr | 143.00 Cr | - | 161.99 Cr | 163.74 Cr | 155.09 Cr | 35.96 Cr |
| EBITDA | 84.00 Cr | 92.00 Cr | 32.00 Cr | 16.00 Cr | 73.00 Cr | 135.00 Cr | 187.00 Cr | - | 184.02 Cr | 204.82 Cr | 258.25 Cr | 123.15 Cr |
| Interest Expense | 24.00 Cr | 24.00 Cr | 31.00 Cr | 32.00 Cr | 41.00 Cr | 48.00 Cr | 42.00 Cr | - | 41.13 Cr | 67.62 Cr | 120.00 Cr | 81.18 Cr |
| Pretax Income | 53.00 Cr | 50.00 Cr | -6.00 Cr | -31.00 Cr | 17.00 Cr | 58.00 Cr | 105.00 Cr | - | 80.38 Cr | 58.59 Cr | 64.58 Cr | -31.99 Cr |
| Tax Provision | -2.12 Cr | 14.00 Cr | 1.56 Cr | 6.82 Cr | 13.94 Cr | 28.42 Cr | 39.90 Cr | - | 40.57 Cr | 5.63 Cr | -51.23 L | -45.51 L |
| Net Income | 55.00 Cr | 36.00 Cr | -4.00 Cr | -24.00 Cr | 3.00 Cr | 30.00 Cr | 65.00 Cr | - | 52.11 Cr | -92.75 Cr | -139.05 Cr | 27.63 Cr |
| Diluted EPS | 5.11 | 3.30 | -0.96 | -2.18 | 0.04 | 2.23 | 3.56 | - | 3.33 | -5.49 | -8.03 | 1.44 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 426.00 Cr | 479.00 Cr | 669.00 Cr | 1,016.00 Cr | 1,087.00 Cr | 1,232.00 Cr | 1,475.00 Cr | - | 2,060.10 Cr | 1,951.72 Cr | 2,023.79 Cr | 2,323.90 Cr |
| Current Assets | - | - | - | - | - | - | - | - | 1,087.82 Cr | 1,000.67 Cr | 1,183.39 Cr | 1,236.49 Cr |
| Cash & Equivalents | - | - | - | - | - | - | - | - | 93.74 Cr | 80.25 Cr | 104.07 Cr | 108.56 Cr |
| Inventory | - | - | - | - | - | - | - | - | 568.14 Cr | 512.70 Cr | 526.86 Cr | 503.74 Cr |
| Receivables | - | - | - | - | - | - | - | - | 304.59 Cr | 285.15 Cr | 328.22 Cr | 373.02 Cr |
| Total Liabilities | - | - | - | - | - | - | - | - | 1,236.01 Cr | 1,094.77 Cr | 1,149.01 Cr | 1,323.10 Cr |
| Current Liabilities | - | - | - | - | - | - | - | - | 792.99 Cr | 732.27 Cr | 846.21 Cr | 974.42 Cr |
| Long Term Debt | - | - | - | - | - | - | - | - | 408.10 Cr | 332.72 Cr | 268.30 Cr | 302.61 Cr |
| Total Debt | 160.00 Cr | 180.00 Cr | 331.00 Cr | 373.00 Cr | 461.00 Cr | 539.00 Cr | 550.00 Cr | - | 800.54 Cr | 683.03 Cr | 681.30 Cr | 720.09 Cr |
| Total Equity | 135.00 Cr | 177.00 Cr | 212.00 Cr | 371.00 Cr | 371.00 Cr | 403.00 Cr | 644.00 Cr | - | 819.37 Cr | 864.75 Cr | 901.67 Cr | 1,040.88 Cr |
| Shares Outstanding | - | - | - | - | - | - | - | - | 16.08 Cr | 17.14 Cr | 18.79 Cr | 19.21 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 46.00 Cr | 72.00 Cr | -9.00 Cr | -15.00 Cr | -9.00 Cr | 86.00 Cr | 117.00 Cr | - | 50.90 Cr | 138.98 Cr | 23.00 Cr | 82.07 Cr |
| Investing Cash Flow | -26.00 Cr | -66.00 Cr | -70.00 Cr | -149.00 Cr | -2.00 Cr | -90.00 Cr | -133.00 Cr | - | -124.63 Cr | -66.50 Cr | -75.35 Cr | -52.95 Cr |
| Financing Cash Flow | -15.00 Cr | -7.00 Cr | 91.00 Cr | 182.00 Cr | 26.00 Cr | 3.00 Cr | 39.00 Cr | - | 59.66 Cr | -85.97 Cr | 76.17 Cr | -24.63 Cr |
| Capital Expenditure | -27.00 Cr | -67.00 Cr | -30.00 Cr | -19.00 Cr | -69.00 Cr | -134.00 Cr | -83.00 Cr | - | -144.31 Cr | -60.58 Cr | -42.45 Cr | -57.57 Cr |
| Free Cash Flow | 19.00 Cr | 5.00 Cr | -39.00 Cr | -34.00 Cr | -78.00 Cr | -48.00 Cr | 34.00 Cr | - | -93.41 Cr | 78.41 Cr | -19.45 Cr | 24.50 Cr |
| Net Change in Cash | 4.00 Cr | -1.00 Cr | 13.00 Cr | 18.00 Cr | 15.00 Cr | -1.00 Cr | 23.00 Cr | - | -14.07 Cr | -13.49 Cr | 23.82 Cr | 4.48 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 50.3% | 44.8% | 49.4% | 46.5% |
| Operating Margin % | 12.2% | 15.3% | 1.9% | -1.5% | 4.9% | 9.7% | 12.0% | - | 9.7% | 11.4% | 9.5% | 2.1% |
| Net Margin % | 9.9% | 7.4% | -0.7% | -3.3% | 0.3% | 2.9% | 5.5% | - | 3.1% | -6.5% | -8.5% | 1.6% |
| ROE % | 40.7% | 20.3% | -1.9% | -6.5% | 0.8% | 7.4% | 10.1% | - | 6.4% | -10.7% | -15.4% | 2.7% |
| ROCE % | - | - | - | - | - | - | - | - | 12.8% | 13.4% | 13.2% | 2.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CAMLINFINE
Camlin Fine Sciences Discloses Resignation of Senior R&D Executive - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxOZzNCZnhSUUtscVdCTl90MDFoYTM0TlVlcTFWUTZXTW5ESTIwcnp6OW9hZlJsazdJSHVSR3ZzS09OemQwMTlYUHFlSEg4dzhjc0VSUVRNOHR6QVBFRWMtMVJodTBndkFSSzNqRHhQRjMyZ25CeDRPRWNzTVM3QklObHR2d1Bmbnk3UzRuak…
French Stock Market Authority Clears CAMLIN FINE SCIENCES' Mandatory Tender Offer For Vinpai Shares - TradingView
<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxOMDlrTEpYZ1ZtNzh1Njh1U3JRZEJ2YVB1VndMTGw4dTlCU2FsbjB6Z3ZwTkQ0WmM1WGN5VGtVN2c3Ykp2YVc1NmJlRUY4T3UyNHV6OGR3UGk5eEVOVkNxU29RNXZrRmRYMG9UcFVpY0taZjlNdHNHX0JVaHd5bnhxUGdrcVdHeV92RXdNU0…
Is The Market Rewarding Camlin Fine Sciences Limited (NSE:CAMLINFINE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxQWDhXalRIVlZLNS1GMVBTOFFnTzdSYmNnd2dSZGszX0MwelhpajFpRmVEaDRaZVpXcmk4N0dkS3N2Wk5fbFJ6eE8ycU9lUVR4bXJ0bGVYbGhob1ZPaXZ1MnVoT2MzZXI1NHBEVXBBb1ZHTERQVkRZWElJOTBGSzlZbXE4Yk1vMnBsSzNHd2…
Camlin Fine Sciences Wins AMF Clearance for Mandatory Tender Offer on Vinpai - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxQbTU2a2IzcXVOLUEyc3FRejFvSXduUlRlY1B3RnlKX1JRcnJsUnBhVnN3eXFsMmZtaE1Oa0l1R2xfa2tjalRJNXIxNjBENG9MUXRXN1VWVjB5TXNwLU11MkpDbXBXVU1Kc0R4MnItdlBQcXVmT0dPNDNaNDZ2S0NFNTRyT0owMHg4X0Yzd0…
Camlin Fine Sciences holds analyst meeting in Mumbai - scanx.trade
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOeTgxUVROSFlkOWx6cm4yNGVteGJKZjRiWGJKLUVfOXh4SE91TWZ1Vk5laVB3REMzeENZdmZ1WWN2ZWdvck1mbm4yempLWDE4ZDk0WFpIMktDWmtXZXhIOWp3Z1pEbUUta28yZ0RfSDJfYWNJZE1yRWE4V09sc3ZZQ2lXMXpWY3luNlgzek…
Camlin Fine Sciences Limited's (NSE:CAMLINFINE) market cap up ₹5.7b last week, benefiting both retail investors who own 35% as well as insiders - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNSHlHUjhQNFVyTDgzRXJZMk55cEJYdThXQ0NHZXMxVEtid1ItU1pDSnExUGxmNWtpX3BpcHJjV2tPWGtscUVHZFZNbW1VYlM2QnlkcW1ORzhYVHI3WXJtdHpTOVRyd3BFdDVrQnV6ME1vZXNQU2g5eUhXUnJleXcwRW1wZE1IenJVS3d4Ym…
CAMLINFINE — Frequently Asked Questions
What is the current share price of CAMLINFINE?
As of 2026-07-15 09:52 IST, CAMLINFINE trades at ₹127.41 on NSE. Its 52-week range is ₹96.93 to ₹295.15.
What is the market capitalisation of CAMLINFINE?
CAMLINFINE has a market capitalisation of ₹2,447.44 Cr on NSE.
What is the P/E ratio of CAMLINFINE?
CAMLINFINE trades at a trailing price-to-earnings (P/E) ratio of 88.48. Its price-to-book (P/B) ratio is 2.33.
What is the return on equity (ROE) of CAMLINFINE?
CAMLINFINE has a return on equity (ROE) of 2.65%. Its return on capital employed (ROCE) is 2.66%.
Is CAMLINFINE a good stock to buy?
This page provides a data-driven analysis of CAMLINFINE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.